OCEAN: A Breakthrough in AFib Research
Every breakthrough begins with a question. “If my ablation was successful and my atrial fibrillation is gone or greatly reduced, why do I still need to take a blood thinner?”
It strikes without warning… bringing a racing heartbeat and the fear of worsening symptoms.
For many people living with atrial fibrillation (Afib), the most common type of irregular heart rhythm, this is their reality. In fact, it is estimated that one in three people will develop Afib during their lifetime. The demand for gold-standard Afib treatments is also growing at an extraordinary pace. Over the past four years, the number of catheter ablations administered in Ontario has increased 143%.
